Supplementary Tables S1-S2 from An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance

Abstract

<p>Supplementary Table 1. Clinical characteristics of 85 primary breast tumors used for statistical analysis; Supplementary Table 2. HER2 and HER2�16 coexpression compared clinicopathological parameters.</p>